Treatment of Mild Hypertension Study - TOMHS
Description:
To compare five drug treatments with placebo for long-term treatment of mild hypertension.
Hypothesis:
The combination of dietary and behavioral changes with drug monotherapy will result in significant reduction in blood pressure.
Study Design
Study Design:
Patients Screened: Not reported
Patients Enrolled: 902
NYHA Class: Not Reported
Mean Follow Up: mean follow-up 4.4 years
Mean Patient Age: 45-69
Female: 38%
Mean Ejection Fraction: Not Evaluated
Patient Populations:
Diastolic blood pressure 90-99 mmHg, or if previously treated with antihypertensive drugs, 85-99 mmHg.
Exclusions:
History or evidence of cardiovascular disease or LV hypertrophy (based on ECG).
Primary Endpoints:
change in diastolic and sytolic blood pressure
Secondary Endpoints:
left ventricular mass, plasma lipid levels, death and major cardiovascular events (nonfatal MI, stroke, CHF, surgery for aortic aneurysm, CABG surgery, coronary angioplasty, thrombolytic therpay, hospitalization for unstable angina)
Drug/Procedures Used:
Chlorthalidone 15 mg/day (diuretic), acebutolol 400 mg/day (β-blocker), doxazosin 1 mg/day (alpha-1 agonist), amlodipine 5 mg/day, enalapril 5 mg/day, or placebo (all a.m. dosing). All patients received nutritional-hygienic advice (low weight, low sodium, low alcohol, increased exercise).
Principal Findings:
Drug therapy reductions were sizable and similar in all treatment groups (DBP decreased by 11.5 to 13.1 mmHg [vs 8.6 mmHg for placebo] and SBP decreased by 14.2 to 17.7 mmHg [vs 9.1 mmHg for placebo]). Drug groups had a nonsignificant reduction in death and major cardiovascular events (5.1% vs. 7.3%; p = 0.21). The only significant difference vs placebo for reduction in LV mass was with chlorthalidone (p=0.03). Drug therapy also was associated with better quality of life and decreased resting ECG abnormalities.
Interpretation:
The addition of any one of five different classes of drugs to dietary and behavioral modifications resulted in significant additional reduction in blood pressure with few side effects.
References:
JAMA 1993;270:713–724. Circulation 1995;91:698-706. LV mass assessment.
Clinical Topics: Diabetes and Cardiometabolic Disease, Prevention, Statins, Diet, Hypertension
Keywords: Enalapril, Chlorthalidone, Sodium, Diuretics, Doxazosin, Electrocardiography, Calcium Channel Blockers, Diet, Sodium-Restricted, Quality of Life, Amlodipine, Hypertension
< Back to Listings